XORTX Therapeutics (XRTX) - 2023 Q4 - Annual Report

Exhibit 99.1 CONSOLIDATED FINANCIAL STATEMENTS AS AT AND FOR THE YEARS ENDED DECEMBER 31, 2023, 2022 and 2021 (Expressed in U.S. Dollars) REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM TO THE SHAREHOLDERS AND DIRECTORS OF XORTX THERAPEUTICS INC. Opinion on the Consolidated Financial Statements We have audited the accompanying consolidated statements of financial position of Xortx Therapeutics Inc. (the "Company") and its subsidiaries as of December 31, 2023 and 2022 and January 1, 2022, and the rel ...